The Smart
Inhaler Market is projected to gain market revenue of US$ 4,563.1 million
by 2026, growing at a CAGR of 15.72% during the forecast period 2020-2026.
Owing to the rising adoption of Smart Inhaler services due to the rapid
increase in the aging population along with respiratory disorders associated
with them. Moreover, increasing incidence of respiratory diseases, the rise in
air pollution, and growth in healthcare burden owing to higher cases of asthma
and COPD. Better treatment options, ease of use, and technological advancements
coupled with the increase in adherence rate of patients to smart inhalers are
other major factors that drive this market. Healthcare is the fundamental
necessity of every individual however; the soaring cost of healthcare makes it
unaffordable for several people. Moreover, the lack of reimbursement and
limited availability of smart inhalers in developing regions are expected to
restrain the global smart inhalers' market growth. These inhalers Inhalers and nebulizers are bifurcated
into metered-dose inhalers, dry powder inhalers and nebulizers.
For Regional/country-wise analysis of the overall adoption
of smart inhaler technology for different respiratory disorders browse
through – https://univdatos.com/report/smart-inhaler-market-current-analysis-and-forecast-2019-2026
Based
on product type, the report bifurcates the global smart inhalers market into
Inhaler (Metered Dose Inhalers, Dry Powder Inhalers) and nebulizers.
The market of metered-dose inhalers is expected to grow tremendously at a CAGR
of 15.1% during the forecast period 2020-2026, due to the high adoption of
these devices. Based on indication, the global smart inhaler market is
segmented into Chronic Obstructive Pulmonary Disorder (COPD) and asthma. The
COPD occupied the largest share and is expected to maintain its dominance
throughout the forecast period 2020-2026 owing to COPD is expected to be the
third leading cause of death globally by 2030. The segment generated revenue of
US$ 835.5 million in 2018. Chronic
Obstructive Pulmonary Disease (COPD) is a general term that describes
progressive respiratory diseases like emphysema and chronic bronchitis. Asthma
is usually considered a separate respiratory disease, but sometimes it’s
mistaken for COPD. According to the National Institutes of Health Trusted
Source (NIH), around 24 million in America alone have COPD. Amongst
the prevalence of COPD and asthma, COPD is expected
to be the third leading cause of death globally by 2030. COPD is a
life-threatening disease that accounts for about 5% of the yearly global
deaths. Thus, the increasing prevalence of COPD will provide growth to the
smart inhaler market over the forecast period.
Request
for Sample of the report – https://univdatos.com/request_form/form/232
Based on Distribution Channel, the report bifurcates
the market into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.
In 2018, Hospital Pharmacies segment generated revenue of US$ 1,015.03 million,
however, Online Pharmacies segment is expected to witness highest CAGR growth
of 23.5% during the analyzed period. For in-depth understanding of the market
adoption of Smart Inhaler, the industry is analyzed based on geographies and
countries comprising North America (the U.S, Canada and rest of North America),
Europe (Germany, Spain, the U.K., France, Italy and Rest of Europe),
Asia-Pacific (Japan, India, China, Australia and Rest of Asia-Pacific), and
Rest of the World. Further, the rise in geriatric population and age-related
respiratory disorders such as COPD in North America as well as Asia-Pacific are
estimated to fuel the Smart Inhaler market in both the regions in the upcoming
years.
To
analyze the ongoing and projected development under the smart inhaler
technology browse through - Smart Inhalers Market
Boehringer Ingelheim, Cohero Health,
Inc., Omron Corporation, Novartis, AstraZeneca, Teva Pharmaceuticals Industries
Ltd., Vectura Group, GlaxoSmithKline, Adherium Limited, 3M are
some of the prominent players operating in the Global Smart Inhaler market.
Several M&A’s along with partnerships have been undertaken by these players
to facilitate costumers with hi-tech and innovative products.
Global Smart Inhaler Market Segmentation
Market Insights, by Product Type
Inhalers
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Market Insights, by Indication
COPD
Asthma
Market Insights, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market Insights, by End-User
Hospitals & Clinics
Respiratory Care Centre
Others
Market Insights, by Region
North America Smart Inhaler market
United States
Canada
Rest of North America
Europe Smart Inhaler market
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific Smart Inhaler market
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World Smart Inhaler market
Top Company Profiles
Boehringer Ingelheim group
Cohero Health, Inc.
Omron Corporation
Novartis AG
AstraZeneca plc
Teva Pharmaceutical Industries Limited
Vectura Group plc
GlaxoSmithKline
Adherium Limited
3M Drug Delivery Systems
Feel
free to contact us for any queries – https://univdatos.com/request_form/form/232
UnivDatos Market Insights (UMI)
understands that you may have your own business need, hence we also provide
fully customized solutions to clients. The Global Smart Inhalers Market can be
customized to the country level or any other market segment.
Contact Us
UnivDatos Market Insights (UMI)
Comments